Archive - June 2012
Friday, June 29, 2012 - 9:46am
Kristen and Brandee, members of the AYA and Pediatric Psychosocial team at RPCI, will be sharing new insights and advice for the AYA population each month on Cancer Talk.
Cancer doesn’t define you; it’s just a piece of your story.
This is important for all cancer patients to remember, but particularly for those who are in the “Adolescents and young adult's" (AYA) age group, or between 15 - 39 years old. A new member of this group is diagnosed with cancer...
Wednesday, June 27, 2012 - 8:32am
Anurag Singh, MD, Radiation Oncologist and Director of Clinical Radiation Research at RPCI, joins this week's edition of Roswellness Radio to discuss radiation therapy. In addition to clearing up misconceptions about the treatment, Dr. Singh explains exactly what radiation therapy entails, the types of patients who should consider receiving it, and why it can be of great value.
Friday, June 22, 2012 - 11:30am
Earlier this month, a British study published in The Lancet revealed that computed tomography (CT) scans can raise the risk of brain cancer and leukemia in children later in life. The study may very well make some parents wonder about the necessity of a CT scan for their child and whether it’s worth the possibility of negative long-term effects.
The study itself was very well done, but I want to emphasize to parents that the risk factor, in this case, is still very low. The immediate benefits of a CT scan to a patient suffering from serious head injuries or...
Wednesday, June 20, 2012 - 11:37am
When Steven Rukavina was diagnosed with multiple myeloma, he looked to RPCI and Dr. Philip McCarthy, Director of Blood & Marrow Transplant, to help him beat this rare blood disease. As a participant in a study led by Dr. McCarthy, involving treatment with the drug lenalidomide, Steven was able to curb relapse after a stem cell transplant and continue on the road to recovery.
Tuesday, June 19, 2012 - 11:57am
After breast cancer survivor, and TV personality Robin Roberts revealed a recent diagnosis of myelodysplastic syndrome (MDS) on ABC’s “Good Morning America,” I was asked to demystify the disease and help educate the public. MDS is a cancer of the bone marrow that causes stem cell abnormalities and a disruption of blood and platelet production. What I often see in patients with MDS is too many young cells that don’t mature or function properly. Because of this, patients are often left anemic and fatigued. They bruise or bleed easily due to low platelets and sustain...
Thursday, June 7, 2012 - 3:48pm
Cancer treatment, as many patients can attest, can cause unwelcome side effects. One of the major focuses of research undertaken by our Cell Stress Biology Department at Roswell Park is to find ways to reduce these side effects and improve the quality of life for our patients.
The result of one such study, now more than nine years in the making, was the development of the drug CBLB502. This drug holds dual promise because in addition to reducing cancer treatment side effects it also has potential...
